TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
BioArctic AB
Closing information (x1000 EUR)
| Closing information | 2024/12 (consolidated) | 2023/12 (consolidated) | 2022/12 (consolidated) |
| Turnover |
22,405
|
55,515
|
20,514 |
| Financial expenses |
161
|
936
|
67 |
| Earnings before taxes |
-16,499
|
24,918
|
-1,004 |
| EBITDA |
-18,961
|
24,429
|
-252 |
| Total assets |
96,782
|
106,892
|
77,128 |
| Current assets |
87,987
|
103,888
|
73,762 |
| Current liabilities |
15,293
|
11,262
|
6,370 |
| Equity capital |
77,913
|
94,320
|
70,652 |
| - share capital |
154
|
159
|
158 |
| Employees (average) |
97
|
80
|
55 |
Financial ratios
| Fiscal year | 2024/12 (consolidated) | 2023/12 (consolidated) | 2022/12 (consolidated) |
| Solvency |
80.5%
|
88.2%
|
91.6% |
| Turnover per employee |
231
|
694
|
373 |
| Profit as a percentage of turnover |
-73.6%
|
44.9%
|
-4.9% |
| Return on assets (ROA) |
-16.9%
|
24.2%
|
-1.2% |
| Current ratio |
575.3%
|
922.5%
|
1158.0% |
| Return on equity (ROE) |
-21.2%
|
26.4%
|
-1.4% |
| Change turnover |
-31,223
|
34,941
|
18,435 |
| Change turnover % |
-58%
|
170%
|
886% |
| Chg. No. of employees |
17
|
25
|
9 |
| Chg. No. of employees % |
21%
|
45%
|
20% |
Total value of public sale
| Fiscal year | 2024/12 (consolidated) | 2023/12 (consolidated) | 2022/12 (consolidated) |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.